Magnetic resonance imaging‐based radiomics nomogram for the evaluation of therapeutic responses to neoadjuvant chemohormonal therapy in high‐risk non‐metastatic prostate cancer

Ähnliche Einträge

• Development and Validation of an MRI‐Based Radiomics Nomogram to Predict the Prognosis of De Novo Oligometastatic Prostate Cancer Patients
  von: Wen‐Qi Liu, et al.
  Veröffentlicht: (2024)
• MR imaging of breast cancer: Interpretable radiomics analysis to assess treatment response and survival prognosis after neoadjuvant therapy
  von: Jie Hou, et al.
  Veröffentlicht: (2025)
• Dose compliance of estramustine phosphate in neoadjuvant chemohormonal therapy combined with degarelix acetate predicts the biochemical recurrence in patients with very high‐risk prostate cancer who underwent robot‐assisted radical prostatectomy
  von: Takanari Kambe, et al.
  Veröffentlicht: (2024)
• MRI‐based qualitative, quantitative, and radiomics/deep learning methods for assessing treatment response after neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer
  von: Shuang Chen, et al.
  Veröffentlicht: (2026)
• Guangqi: A two-dimensional radiation hydrodynamic code with realistic equation of states
  von: Chen, Zhuo, et al.
  Veröffentlicht: (2026)